Skip to main content

Animations

MJFF Publications

4171 - 4180 of 8808 Results
Title
Year
  • Year
  • 2016
  • 2019
  • 2019
  • 2024
  • 2018
  • 2023
  • 2022
  • 2022
  • 2019
  • 2019
  • Summary Details
    OPEN
    Title: LRRK2 phosphorylates pre-synaptic N-ethylmaleimide sensitive fusion (NSF) protein enhancing its ATPase activity and SNARE complex disassembling rate
    Journal Name: Molecular Neurodegeneration
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1186/s13024-015-0066-z
    Citation Count: 171
  • Summary Details
    OPEN
    Title: Bundled Three-Dimensional Human Axon Tracts Derived from Brain Organoids
    Journal Name: iScience
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.isci.2019.10.004
    Citation Count: 51
  • Summary Details
    OPEN
    Title: Factors in the disease severity of ATP1A3 mutations: Impairment, misfolding, and allele competition
    Journal Name: Neurobiology of Disease
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.nbd.2019.104577
    Citation Count: 41
  • Summary Details
    OPEN
    Title: Genetic and pharmacological reduction of CDK14 mitigates synucleinopathy
    Journal Name: Cell Death & Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1038/s41419-024-06534-8
    Citation Count: 5
  • Summary Details
    OPEN
    Title: A Culturally Tailored Community Health Worker Intervention Leads to Improvement in Patient-Centered Outcomes for Immigrant Patients With Type 2 Diabetes
    Journal Name: Clinical Diabetes
    Publisher: American Diabetes Association
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.2337/cd17-0068
    Citation Count: 53
  • Summary Details
    OPEN
    Title: Embracing Monogenic Parkinson's Disease: The MJFF Global Genetic PD Cohort
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1002/mds.29288
    Citation Count: 38
  • Summary Details
    OPEN
    Title: Rapid ex vivo reverse genetics identifies the essential determinants of prion protein toxicity
    Journal Name: Brain Pathology
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1111/bpa.13130
    Citation Count: 4
  • Summary Details
    OPEN
    Title: Effect of LRRK2 protein and activity on stimulated cytokines in human monocytes and macrophages
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41531-022-00297-9
    Citation Count: 33
  • Summary Details
    OPEN
    Title: The second generation mixed lineage kinase-3 (MLK3) inhibitor CLFB-1134 protects against neurotoxin-induced nigral dopaminergic neuron loss
    Journal Name: Experimental Neurology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.expneurol.2019.05.002
    Citation Count: 11
  • Summary Details
    RESTRICTED
    Title: Revisiting the non-Gaucher-GBA-E326K carrier state: Is it sufficient to increase Parkinson's disease risk?
    Journal Name: Molecular Genetics and Metabolism
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.ymgme.2019.10.001
    Citation Count: 37
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.